Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Lead Sponsor:

Southlake Regional Health Centre

Collaborating Sponsors:

Applied Health Research Centre

Conditions:

Persistent Atrial Fibrillation

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

Catheter ablation has emerged as an effective therapy for atrial fibrillation (AF). However, achievement of complete\& durable isolation of the pulmonary veins (PVs) is challenging, primary limited bo...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Age \> 18 years.
  • Patients undergoing first-time catheter ablation for AF.
  • Persistent AF defined as episodes greater than 7 days duration.
  • Symptomatic AF defined as patients who have been aware of their AF anytime within the last 5 years prior to enrolment. Symptoms may include, but are not restricted to, palpitations, shortness of breath, chest pain, fatigue, left ventricular dysfunction, or other symptoms, or any combination of the above.
  • At least one episode of AF must have been documented by ECG, Holter, loop recorder, telemetry, implanted device, or transtelephonic monitoring within 24 months of enrolment.
  • Willing and able to provide informed consent.
  • Exclusion Criteria
  • Paroxysmal AF.
  • AF secondary to a reversible cause.
  • Patients with contraindications to systemic anticoagulation with heparin, coumadin, or a direct thrombin inhibitor.
  • Patients who have previously undergone AF ablation.
  • Patients with left atrial size \>55 mm (echocardiography, parasternal long axis view).
  • Patients who are or may potentially be pregnant.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 15 2017

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT01851525

    Start Date

    June 1 2013

    End Date

    February 15 2017

    Last Update

    April 25 2017

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Vancouver Island Cardiac Arrhythmia Clinic

    Victoria, British Columbia, Canada, V8R 4R2

    2

    Southlake Regional Health Centre

    Newmarket, Ontario, Canada, L3Y 2P9

    3

    Montreal Heart Institute

    Montreal, Quebec, Canada, H1T 1C8

    4

    Laval University Cardiac and Pulmonary Institute

    Québec, Quebec, Canada, G1V 0A6